Daniel Wolfe

Functions as a College/University

Functions as a College/University

Operates as closed-end management investment company

Develops monoclonal antibodies for diagnosis and treatment of infectious, autoimmune and inflammatory diseases

Provides waste treatment solutions and services to the oil and gas industry

BC Partners focuses on leading buy-outs of larger businesses in the region and selectively outside Europe through its established network of offices in London, Paris, Hamburg, Milan and New York. The firm is an active, long-term manager that concentrates on large, multi-country transactions which typically have significant operations in Europe even when the principal place of business is elsewhere. They target a small number of companies, seeking a seat on the board of directors and partnering with management to implement the business plan and identify opportunities for value creation. BC Partners typically invests in high quality businesses which enjoy strong competitive positions in their industry. They focus on business fundamentals rather than sector specialization, placing particular value on pricing or cost leadership, demonstrated resilience to cycle downturns, profit improvement potential, and a high quality management team. The firm can invest over €2 billion per transaction and can contribute significant financial reserves to grow an acquired business.

Develops energy storage devices such as capacitators

Provides integrated oil, gas and water separation solutions

Operates as a blank check company

180-IM aims to generate capital appreciation and current income from investments and investment-related activities. The firm focuses on publicly traded micro-cap companies and invests where their research suggests a company is deeply undervalued and can positively impact the business and valuation through constructive activism.